← Back to Search

Vitamin D Formulation

Regular Vitamin D3 1000IU for Vitamin D

N/A
Waitlist Available
Research Sponsored by Factors Group of Nutritional Companies Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at day 0 (before treatment), at day 5, 10, 15 (during treatment), at day 30 (end of treatment), at day 45 and 60 (after treatment).
Awards & highlights

Study Summary

This trial is testing two different concentrations of vitamin D to see which is more effective. They are also testing a new microencapsulated LipoMicel Vitamin D formulation to see if it is more effective than the regular vitamin D formulation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at day 0 (before treatment), at day 5, 10, 15 (during treatment), at day 30 (end of treatment), at day 45 and 60 (after treatment).
This trial's timeline: 3 weeks for screening, Varies for treatment, and at day 0 (before treatment), at day 5, 10, 15 (during treatment), at day 30 (end of treatment), at day 45 and 60 (after treatment). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Weight Changes
Evaluation of Vitamin D serum level: change of 25-Hydroxyvitamin D
Secondary outcome measures
Safety blood work evaluation - change of C Reactive Protein (CRP)
Safety blood work evaluation - change of alanine aminotransferase (ALT)
Safety blood work evaluation - change of alkaline phosphatase
+8 more

Trial Design

4Treatment groups
Active Control
Group I: Regular Vitamin D3 1000IUActive Control1 Intervention
The first group receives regular Vitamin D3 1000IU
Group II: Microencapsulated Vitamin D3 1000IUActive Control1 Intervention
The second group receives microencapsulated Vitamin D3 1000IU
Group III: Regular Vitamin D3 2500IUActive Control1 Intervention
The third group receives regular Vitamin D3 2500IU
Group IV: Microencapsulated Vitamin D3 2500IUActive Control1 Intervention
The fourth group receives microencapsulated Vitamin D3 2500IU

Find a Location

Who is running the clinical trial?

Factors Group of Nutritional Companies Inc.Lead Sponsor
7 Previous Clinical Trials
194 Total Patients Enrolled
~11 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top